RMD Forensic analysis

Trading Setup & Entry Strategy

ResMed (RMD) is currently in a BEARISH_DOWNTREND with price action trading significantly below both the 50-day SMA ($220.69) and the 200-day SMA ($251.82). While the MACD is showing a modest BULLISH signal, the broader momentum remains negative. We are adopting a patient stance to avoid catching a falling knife.

• >Entry Zone: $195.50 - $198.50. We want to see a test of the Lower Bollinger Band ($195.66).
• >Stop Loss: $189.00 (Hard). Exit if the stock fails to hold the psychological $190 support.
• >Position Sizing: 2% of portfolio. This is a mean-reversion trade in a downtrend, demanding tight discipline.
• >Scaling Strategy: Enter 50% at $198.00; add 50% at $196.00.
• >Take Profit: $215.00 (initial) and $222.00 (full exit near the 50-day SMA resistance).
• >Risk/Reward: ~1:2.5.
• >Max Hold Time: 10 trading days.

Executive Summary

ResMed (RMD) continues to deliver solid top-line growth (+11% YoY revenue) and expanding margins, but the stock is currently struggling against a technical BEARISH_DOWNTREND. With an RSI of 43.41, the stock is in "no-man's land," requiring a definitive test of support before establishing a long-term position. Analysis date: 2026-05-20.

Recent Material Events (8-K Analysis)

Recent filings indicate routine corporate governance updates. No material negative surprises (e.g., litigation settlements or debt defaults) have been disclosed since the Q3 filing. The focus remains on the integration of SaaS assets and device manufacturing efficiency.

Insider Trading Activity

Recent Form 4s show executive selling (notably on May 11, 2026). While standard, this aligns with the current price weakness, suggesting management is not aggressively defending the current valuation at these levels.

Financial Health & Forensics

• >Revenue Quality: Strong. Revenue growth of 11% with gross margins improving to 62.2%.
• >Debt: The company has ~$664M in total debt with a solid cash position of $1.66B. Interest coverage is healthy.
• [WARN]** Warning**: Accounts Receivable increased to $998.8M from $939.5M, and prepaid assets have spiked. Monitor these to ensure conversion into cash remains efficient.

Technical Analysis & Trade Timing

• >Trend: BEARISH_DOWNTREND; price is below major moving averages.
• >Momentum: Neutral RSI (43). MACD is flashing a buy signal, but volume is not confirming a trend reversal.
• >Reconciliation: Fundamentals are strong, but the technicals suggest the market is re-pricing the stock's growth multiple. We respect the trend and will not chase until the $195-$198 support base is proven.